DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/k3w8fl/glaucoma) has announced the addition of the "Glaucoma - Pipeline Review, H1 2013" report to their offering.
This analysis provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Glaucoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glaucoma.
It is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
- A snapshot of the global therapeutic scenario for Glaucoma.
- A review of the Glaucoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Glaucoma pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
Latest news and deals relating to the products.
Key Topics Covered:
List of Tables
List of Figures
An Overview of Pipeline Products for Glaucoma Therapeutics under Development by Companies
Glaucoma Therapeutics under Investigation by Universities/Institutes
Companies Involved in Glaucoma Therapeutics Development
Glaucoma - Therapeutics Assessment
Glaucoma Therapeutics - Drug Profile Updates
Glaucoma Therapeutics - Discontinued Products
Glaucoma Therapeutics - Dormant Products
Glaucoma - Product Development Milestones
Featured News & Press Releases
- AC Immune SA
- ACADIA Pharmaceuticals Inc.
- Advanced Cell Technology, Inc.
- Aerie Pharmaceuticals, Inc.
- Alcon, Inc.
- Allergan, Inc.
- Altacor Ltd.
- Applied Genetic Technologies Corporation
- Ascenion GmbH
- Can-Fite BioPharma Ltd.
- CeNeRx BioPharma, Inc.
- Ceregene, Inc.
- Colby Pharmaceutical Company
- Foamix Ltd.
- ISTA Pharmaceuticals, Inc.
- Icon Bioscience, Inc.
- InSite Vision Incorporated
- Intellect Neurosciences, Inc.
- Kowa Company, Ltd.
- LABORATOIRES THEA
- Lacer, S.A.
- Merz GmbH & Co. KGaA
- Mimetogen Pharmaceuticals Inc.
- NeoStem, Inc.
- Neurotech Pharmaceuticals, Inc.
- Novagali Pharma SA
- Ono Pharmaceutical Co., Ltd.
- Oxford BioMedica plc
- PharmaNova Inc.
- Phytopharm Plc
- Proneuron Biotechnologies, Inc.
- Proximagen Neuroscience plc.
- Quark Pharmaceuticals, Inc.
- SIFI Pharma
- Santen Pharmaceutical Co., Ltd.
- Senju Pharmaceutical Co., Ltd.
- Summit Corporation plc
For more information visit http://www.researchandmarkets.com/research/k3w8fl/glaucoma